Search
Search Results
-
Dose–effect relationships in neuroendocrine tumour liver metastases treated with [166Ho]-radioembolization
PurposeAim of this study was to investigate a dose-response relationship, dose-toxicity relationship, progression free survival (PFS) and overall...
-
Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
BackgroundFor safe and effective holmium-166 ( 166 Ho) liver radioembolization, dosimetry is crucial and requires accurate healthy liver definition....
-
Sequential Y90 liver radioembolization and portal vein embolization: an additional strategy to downstage liver tumors and to enhance liver hypertrophy before major hepatectomies
BackgroundYttrium (Y) 90 liver radioembolization (TARE) induces both tumor downsizing and contralateral liver hypertrophy. In this study, we report...
-
Transarterial Radioembolization to Impact Liver Volumetry: When and How
Inadequate volume of the future liver remnant (FLR) renders many patients with liver malignancies not amenable to surgical resection. Depending on...
-
90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry
PurposeEvaluation of 90 Y liver radioembolization post-treatment clinical data using a whole-body Biograph Vision Quadra PET/CT to investigate the...
-
Integrated Capecitabine–Temozolomide with Radioembolization for Liver-Dominant G2 NETs: Long-Term Outcomes of a Single-Institution Retrospective Study
PurposeCapecitabine–Temozolomide (CapTem) is an oral chemotherapy regimen for NETs. Both drugs are radiosensitizers. Integrating CapTem and Y90...
-
Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
BackgroundIn hepatocellular carcinoma (HCC) patients, intraarterial therapies are regularly employed as a bridge to liver transplantation to prevent...
-
Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis
PurposeTumorigenesis in NAFLD/NASH-induced HCC is unique and may affect the effectiveness of trans-arterial radioembolization in this population. The...
-
Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing 99mTc-MAA and 90Y-microspheres radioembolization
PurposeThis study aimed to determine the absorbed doses in the tumoral-liver and non-tumoral liver of hepatocellular carcinoma (HCC) patients...
-
Role of Radioembolization in Metastatic Neuroendocrine Tumors
The liver is the most common site of metastasis for neuroendocrine tumors originating from the gastrointestinal tract. Neuroendocrine liver...
-
SPECT and CT misregistration reduction in [99mTc]Tc-MAA SPECT/CT for precision liver radioembolization treatment planning
PurposeRespiration and body movement induce misregistration between static [ 99m Tc]Tc-MAA SPECT and CT, causing lung shunting fraction (LSF) and...
-
Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review
BackgroundTransarterial radioembolization with yttrium-90 (Y-90 TARE) microspheres therapy has demonstrated positive clinical benefits for the...
-
Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90)
PurposeThe primary objective of the REMEMBR Y90 study is to evaluate the efficacy of Yttrium-90 (Y90) radioembolization in patients with breast...
-
Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review
PurposeStrategies for the treatment of liver metastases from colon cancer (lmCRC) are constantly evolving. Radioembolization with yttrium 90 (Y-90...
-
Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE)
PurposeAn international survey was conducted by the Cardiovascular Interventional Radiological Society of Europe (CIRSE) to evaluate...
-
Holmium-166 Radioembolization: Current Status and Future Prospective
Since its first suggestion as possible option for liver radioembolization treatment, the therapeutic isotope holmium-166 ( 166 Ho) caught the experts’...
-
Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes
BackgroundLiver surgery after radioembolization (RE) entails highly demanding and challenging procedures due to the frequent combination of large...
-
Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere
PurposeTo compare the treatment outcomes of glass and resin microspheres for the treatment of hepatocellular carcinoma (HCC) and evaluate the...
-
Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization
PurposeTo evaluate the relationship between non-tumor liver (NTL) dose and adverse events (AE) in patients with hepatocellular carcinoma (HCC)...
-
Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer
PurposeTo evaluate the benefit of a contrast-enhanced computed tomography (CT) radiomics-based model for predicting response and survival in patients...
